Anika Announces FDA 510(k) Clearance for Its Injectable HA-Based Bone Repair Treatment 02/01/2018 iData Research Anika Therapeutics, Inc., a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, recently announced that its HA-base... Read More
